Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

The TRICURE EU Pivotal Study

NCT: NCT06581471 · RECRUITING

NCT IDNCT06581471
StatusRECRUITING
Start Date2024-08-29
Completion2030-12-30

Brief Summary

Prospective, multi-center study to assess safety and performance of the TRiCares Topaz Tricuspid Valve Replacement System

Frequently Asked Questions

What is The TRICURE EU Pivotal Study?

The TRICURE EU Pivotal Study is a clinical trial registered under NCT06581471. Current status: RECRUITING.

What is the status of NCT06581471?

The current status of NCT06581471 (The TRICURE EU Pivotal Study) is: RECRUITING.

When did The TRICURE EU Pivotal Study start?

The TRICURE EU Pivotal Study started on 2024-08-29.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.